Story perspectives

Clopidogrel Outperforms Aspirin in Heart Attack Prevention

8/31/2025

36 3

Summary

Story summary

A study indicates clopidogrel is more effective than aspirin in reducing heart attack and stroke risks for coronary artery disease (CAD) patients.
The research, involving nearly 29,000 patients, shows a 14% lower risk of major cardiovascular events with clopidogrel, without increased bleeding risks.
Findings were presented at the European Society of Cardiology congress and published in The Lancet.
Experts recommend clopidogrel for clinical use due to its affordability and effectiveness.
CAD impacts 2.3 million individuals in the UK.

1 of 1

Story summary

A study indicates clopidogrel is more effective than aspirin in reducing heart attack and stroke risks for coronary artery disease (CAD) patients.
The research, involving nearly 29,000 patients, shows a 14% lower risk of major cardiovascular events with clopidogrel, without increased bleeding risks.
Findings were presented at the European Society of Cardiology congress and published in The Lancet.
Experts recommend clopidogrel for clinical use due to its affordability and effectiveness.
CAD impacts 2.3 million individuals in the UK.